Advanced search
Publication Cover
Expert Review of Vaccines Volume 11, 2012 - Issue 4
Submit an article Journal homepage
379
Views
7
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of influenza vaccination in children with asthma

Maria Francesca Patria Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
,
Rossana Tenconi Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy
&
Susanna Esposito Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy. [email protected]
Pages 461-468 | Published online: 09 Jan 2014

References

  • Lai CKW, Beasley R, Crane J et al. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 64(6), 476–483 (2009).
  • Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J. Allergy Clin. Immunol. 125(6), 1178–1187 (2010).
  • Bartlett NW, McLean GR, Chang YS, Johnston SL. Genetics and epidemiology: asthma and infection. Curr. Opin. Allergy Clin. Immunol. 9(5), 395–400 (2009).
  • Papadopoulos NG, Christodoulou I, Rohde G et al. Viruses and bacteria in acute asthma exacerbations –A GA2LEN. DARE systematic review. Allergy 66(4), 458–468 (2011).
  • Rosenthal LA, Avila PC, Heymann PW et al. Viral respiratory tract infections and asthma: the course ahead. J. Allergy Clin. Immunol. 125(6), 1212–1217 (2010).
  • Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376(9743), 826–834 (2010).
  • Lemanske RF Jr, Jakson DJ, Gangnon RE et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J. Allergy Clin. Immunol. 116(3), 571–577 (2005).
  • Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 377(9773), 1264–1275 (2011).
  • Bourgeois FT, Valim C, Wei JC, McAdam AJ, Mandl KD. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics 118(1), e1–e8 (2006).
  • Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr. Infect. Dis. J. 27(Suppl. 11), S149–S153 (2008).
  • Esposito S, Bosis S, Niesters HG et al. Impact of human coronavirus infections in otherwise healthy children who attended an emergency department. J. Med. Virol. 78(12), 1609–1615 (2006).
  • Fiore AE, Uyeki TM, Broder K et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep. 59(RR-8), 1–62 (2010).
  • Esposito S, Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr. Opin. Infect. Dis. 22(3), 244–249 (2009).
  • Principi N, Esposito S, Marchisio P. Present and future of influenza prevention in pediatrics. Expert Opin. Biol. Ther. 11(5), 641–653 (2011).
  • Esposito S, Marchisio P, Droghetti R et al. Influenza vaccination coverage among children with high-risk medical condition. Vaccine 24(24), 5251–5255 (2006).
  • Glezen WP. Asthma, influenza, and vaccination. J. Allergy Clin. Immunol. 118(6), 1199–1206 (2006).
  • Hanania NA, Sockrider M, Castro M et al. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J. Allergy Clin. Immunol. 113(4), 717–724 (2004).
  • Lee N, Chan PK, Hui DS et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J. Infect. Dis. 200(4), 492–500 (2009).
  • Subrata LS, Bizzintino J, Mamessier E et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J. Immunol. 183(4), 2793–2800 (2009).
  • Miller EK, Griffin MR, Edwards KM et al. Influenza burden for children with asthma. Pediatrics 121(1), 1–8 (2008).
  • Moineddin R, Nie JX, Domb G, Leong AM, Upshur RE. Seasonality of primary care utilization for respiratory diseases in Ontario: a time-series analysis. BMC Health. Serv. Res. 8, 160 (2008).
  • Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical condition, J. Pediatr. 137(6), 856–864 (2000).
  • Khetsuriani N, Kazerouni NN, Erdman DD et al. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 119(2), 314–321 (2007).
  • Bizzintino J, Lee WM, Laing IA et al. Association between human rhinovirus C and severity of acute asthma in children. Eur. Respir. J. 37(5), 1037–1042 (2011).
  • Bosis S, Esposito S, Niesters HG et al. Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrence. Clin. Microbiol. Infect. 14(7), 677–684 (2008).
  • Jartti T, Waris M, Niesters HG, Allander T, Ruuskanen O. Respiratory viruses and acute asthma in children. J. Allergy Clin. Immunol. 120(1), 216 (2007).
  • Mandelcwajg A, Moulin F, Menager C, Rozemberg F, Lebon P, Gendrel D. Understimation of influenza viral infection in chidhood asthma exacerbations. J. Pediatr. 157(3), 505–506 (2010).
  • Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283(4), 499–505 (2000).
  • Coffin SE, Zaoutis TE, Rosenquist AB et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 119(4), 740–748 (2007).
  • Dawood FS, Kamimoto L, D’Mello TA et al. Children with asthma hospitalized with seasonal or pandemic influenza 2003–2009. Pediatrics 128(1), e27–e32 (2011).
  • Dawood FS, Fiore A, Kamimoto L et al. Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003–2008. Pediatr. Infect. Dis. J. 29(7), 585–590 (2010).
  • Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459(7249), 931–939 (2009).
  • Centers for Disease Control and prevention. Update: influenza activity – United States, August 30, 2009–March 27, 2010, and composition of the 2010–2011 influenza vaccine. MMWR Morb. Mortal. Wkly Rep. 59, 423–430 (2010).
  • Lister P, Reynolds F, Parlsow R et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 374(9690), 605–607 (2009).
  • Libster R, Bugna J, Coviello et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N. Engl. J. Med. 362(1), 45–55 (2010).
  • O’Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. Can. Med. Assoc. J. 182(1), 39–44 (2010).
  • Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N. Engl. J. Med. 361(20), 1935–1944 (2009).
  • Patients hospitalized with 2009 pandemic influenza A (H1N1) – New York City, May 2009. MMWR Morb. Mortal. Wkly Rep. 58, 1436–1440 (2010).
  • Hasegawa S, Hirano R, Hashimoto K, Haneda Y, Shirabe K, Ichiyama T. Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals ‘occult’ asthma of childhood. Pediatr. Allergy Immunol. 22(1 Pt 2), e119–e123 (2011).
  • Torres SF, Iolster T, Schnitzler EJ et al. High mortality in patients with influenza A pH1N1 2009 admitted to a pediatric intensive care unit: a predictive model of mortality. Pediatr. Crit. Care Med. 13(2), e78–e83 (2012).
  • Esposito S, Daleno C, Badanti F et al. Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus. Virol. J. 8, 349 (2011).
  • Principi N, Esposito S. Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza. Hum. Vaccin. 7(9), 905–912 (2011).
  • Sant AJ, Chaves FA, Krafcik FR et al. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design. Expert Rev. Vaccines 6(3), 357–368 (2007).
  • Rimmelzwaan GF, Foulchier RA, Osterhaus AD. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr. Opin. Biotechnol. 18(6), 529–536 (2007).
  • Vesikari T. Emerging data on the safety and efficacy of influenza vaccines in children. Pediatr. Infect. Dis. J. 27(Suppl. 11), S159–S161 (2008).
  • Esposito S, Principi N. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination. Vaccine 29(43), 7535–7541 (2011).
  • Ambrose CS, Luke C, Coelingh K. Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Respi. Viruses 2(6), 193–202 (2008).
  • Lanthier PA, Huston GE, Moquin A et al. Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine 29(44), 7849–7856 (2011).
  • Ong BA, Forester J, Fallot A. Does influenza vaccination improve pediatric asthma outcomes? J. Asthma. 46(5), 477–480 (2009).
  • Kramarz P, Destefano F, Gargiulo PM et al. Does influenza vaccination prevent asthma exacerbations in children? J. Pediatr. 138(3), 306–310 (2001).
  • Smiths AJ, Hak E, Stalman WAB, van Essen GA, Hoes AW, Verheij TJM. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol. Infect. 128(2), 205–211 (2002).
  • Sugaya N, Nerome K, Ishida M et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 272, 1122–1126 (1994).
  • Bueving HJ, Bernsen RM, de Jongste JC et al. Influenza vaccination in children with asthma: randomized double-blind placebo controlled trial. Am. J. Respir. Crit. Care Med. 169(4), 488–493 (2004).
  • Christy C, Aligne C, Auinger P, Pulcino T, Weitzman M. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch. Dis. Child 89(8), 734–735 (2004).
  • Zuccotti G, Amendola A, Viganò E et al. Long term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Vaccine 25(37–38), 6692–6698 (2007).
  • Long CB, Ramos I, Rastogi D et al. Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J. Pediatr. 160(1), 74–81 (2011).
  • Busse WW, Peters SP, Fenton MJ et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J. Allergy Clin. Immunol. 127(1), 130–137 (2011).
  • Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 98(2 Pt 1), 196–200 (1996).
  • Fairchok MP, Trementozzi DP, Carter PS, Regnery HL, Carter ER. Effect of prednisone on response to influenza virus vaccine in asthmatic children. Arch. Pediatr. Adolesc. Med. 152(12), 1191–1195 (1998).
  • American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N. Engl. J. Med. 345(21), 1529–1536 (2001).
  • Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 351(9099), 326–331 (1998).
  • Cates CJ, Jefferson TO, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst. Rev. 16(2), CD000364 (2008).
  • Esposito S, Gasparini C, Martelli A et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 26(36), 4664–4668 (2008).
  • Chung EY, Huang L, Schneider L. Safety of influenza vaccine administration in egg-allergic patients. Pediatrics 125(5), e1024–e1030 (2010).
  • Greenhawt MJ, Li JT, Bernstein DI et al. Administering influenza vaccine to egg allergic recipients: a focused practice parameter update. Ann. Allergy Asthma Immunol. 106(1), 11–16 (2011).
  • Owens G, MacGinnitie A. Higher-ovalbumin-content influenza vaccines are well tolerated in children with egg allergy. J. Allergy Clin. Immunol. 127(1), 264–265 (2011).
  • Webb L, Petersen M, Boden S et al. Single-dose influenza vaccination of patients with egg allergy in a multicenter study. J. Allergy Clin. Immunol. 128(1), 218–219 (2011).
  • Howe LE, Conlon AS, Greenhawt MJ, Sanders GM. Safe administration of seasonal influenza vaccine to children with egg allergy of all severities. Ann. Allergy Asthma Immunol. 106(5), 446–447 (2011).
  • Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med. 356(7), 685–696 (2007).
  • Bergen R, Black S, Shinefield H et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr. Infect. Dis. J. 23(2), 138–144 (2004).
  • Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J. 21(1), 44–48 (2002).
  • Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cod-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J. 25(10), 860–869 (2006).
  • Ashkenazi S, Vertruyen A, Arístegui J et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr. Infect. Dis. J. 25(10), 870–879 (2006).
  • Gaglani MJ, Pieda PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr. Infect. Dis. J. 27(5), 444–452 (2008).
  • Tennis P, Toback SL, Andrews E, McQuay LJ, Ambrose CS. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years. Vaccine 29(31), 4947–4952 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.